OsACA9, an Autoinhibited Ca2+-ATPase, Synergically Regulates Disease Resistance and Leaf Senescence in Rice
International Journal of Molecular Sciences · 03.02.2024 · 25 (3) · 1874
DOI: 10.3390/ijms25031874 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.02.2024. Verfasst von Xinyu Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Zhejiang Normal University, Jinhua 321004, China. Hauptthemen laut MEDLINE: Disease Resistance, Oryza. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China, College Students' Science and Technology Innovation Program of Zhejiang Province.
Abstract (Originalsprache)
Calcium (Ca2+) is a versatile intracellular second messenger that regulates several signaling pathways involved in growth, development, stress tolerance, and immune response in plants. Autoinhibited Ca2+-ATPases (ACAs) play an important role in the regulation of cellular Ca2+ homeostasis. Here, we systematically analyzed the putative OsACA family members in rice, and according to the phylogenetic tree of OsACAs, OsACA9 was clustered into a separated branch in which its homologous gene in Arabidopsis thaliana was reported to be involved in defense response. When the OsACA9 gene was knocked out by CRISPR/Cas9, significant accumulation of reactive oxygen species (ROS) was detected in the mutant lines. Meanwhile, the OsACA9 knock out lines showed enhanced disease resistance to both rice bacterial blight (BB) and bacterial leaf streak (BLS). In addition, compared to the wild-type (WT), the mutant lines displayed an early leaf senescence phenotype, and the agronomy traits of their plant height, panicle length, and grain yield were significantly decreased. Transcriptome analysis by RNA-Seq showed that the differentially expressed genes (DEGs) between WT and the Osaca9 mutant were mainly enriched in basal immune pathways and antibacterial metabolite synthesis pathways. Among them, multiple genes related to rice disease resistance, receptor-like cytoplasmic kinases (RLCKs) and cell wall-associated kinases (WAKs) genes were upregulated. Our results suggest that the Ca2+-ATPase OsACA9 may trigger oxidative burst in response to various pathogens and synergically regulate disease resistance and leaf senescence in rice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.
ORCID-Profile: Xinyu Wang, Yiduo Lu, Xifeng Chen
Förderung
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
- College Students' Science and Technology Innovation Program of Zhejiang Province
- College Students’ Science and Technology Innovation Program of Zhejiang Province
Zitieren
APA
Wang, X., Wang, Z., Lu, Y., Huang, J., Hu, Z., Lou, J., Fan, X., Gu, Z., Liu, P., Ma, B., & Chen, X. (2024). OsACA9, an Autoinhibited Ca2+-ATPase, Synergically Regulates Disease Resistance and Leaf Senescence in Rice. International Journal of Molecular Sciences, 25(3), 1874. https://doi.org/10.3390/ijms25031874
Vancouver
Wang X, Wang Z, Lu Y, Huang J, Hu Z, Lou J, et al. OsACA9, an Autoinhibited Ca2+-ATPase, Synergically Regulates Disease Resistance and Leaf Senescence in Rice. International Journal of Molecular Sciences. 2024;25(3):1874. doi:10.3390/ijms25031874
BibTeX
@article{Wang2024,
author = {Wang, Xinyu and Wang, Ziyao and Lu, Yiduo and Huang, Jiani and Hu, Zhuoer and Lou, Junlei and Fan, Xinyue and Gu, Zhimin and Liu, Pengcheng and Ma, Bojun and Chen, Xifeng},
title = {OsACA9, an Autoinhibited Ca2+-ATPase, Synergically Regulates Disease Resistance and Leaf Senescence in Rice},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {3},
pages = {1874},
doi = {10.3390/ijms25031874}
}
EUVIMED